
Articles
-
1 month ago |
psychiatrictimes.com | Megan McSweeney
Lindus Health and Sooma Medical announced a collaboration on a phase 3 clinical trial to evaluate the effectiveness of Sooma’s transcranial direct current stimulation (tDCS) medical device in treating major depressive disorder (MDD).
-
1 month ago |
psychiatrictimes.com | Megan McSweeney
A first-of-its-kind phase 1 open-label clinical trial at Mass General Brigham is evaluating an innovative treatment for Parkinson disease by using a patient’s own reprogrammed stem cells to replace dopamine neurons damaged by the disease. The treatment aims to address the underlying neuronal loss and restore dopamine function.
-
1 month ago |
psychiatrictimes.com | Megan McSweeney
This week, Psychiatric Times discussed a variety of psychiatric issues and industry news, including study trial updates and reflections on emotional resilience from a clinician who lost his home in the California wildfires.
-
1 month ago |
psychiatrictimes.com | Megan McSweeney
In this Research Roundup, we explore new studies examining postpartum depression (PPD), including the potential impact birth complications and life factors have on its development. Drug Use, History of Depression Strong Indicators in the Development of PPDA new study found that psychological factors were the strongest predictors of PPD in women in Mashhad, Iran. The population-based, case-control study investigated PPD among 108,952 women using data from 2017 to 2024.
-
1 month ago |
psychiatrictimes.com | Megan McSweeney
A recent study found that suicidal ideation and firearm access are the strongest predictors of veteran suicide risk, providing critical insight regarding suicide risk indicators among US veterans receiving care through the Veterans Health Administration (VHA). The study, which analyzed over 269,000 suicide risk evaluations conducted from November 2019 to December 2020, identifies key factors that predict suicide risk within both 30 days and 1 year of assessment.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 0
- Tweets
- 0
- DMs Open
- No